NEIL E. FLESHNER - 25 May 2022 Form 4 Insider Report for POINT Biopharma Global Inc.

Role
Chief Medical Officer, Director
Signature
/s/ William L. Demers, by Power of Attorney for Neil E. Fleshner
Issuer symbol
N/A
Transactions as of
25 May 2022
Net transactions value
-$4,237,172
Form type
4
Filing time
26 May 2022, 16:05:35 UTC
Previous filing
31 Mar 2022
Next filing
30 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PNT Common Stock Sale $4,237,172 -564,204 -16% $7.51 3,023,045 25 May 2022 Direct F1
holding PNT Common Stock 233,171 25 May 2022 1510789 Ontario Inc. F2
holding PNT Common Stock 358 25 May 2022 Trust Controlled by Wife F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.75, inclusive. The reporting person undertakes to provide to POINT Biopharma Global Inc., any security holder of POINT Biopharma Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 A corporation controlled by Reporting Person.
F3 A trust, whose trustee is the Reporting Person's spouse.